Your browser doesn't support javascript.
loading
Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study.
Shindo, Tetsuya; Maehana, Takeshi; Tanaka, Toshiaki; Hashimoto, Kohei; Kobayashi, Ko; Takahashi, Atsushi; Hotta, Hiroshi; Kunishima, Yasuharu; Taguchi, Keisuke; Tachiki, Hitoshi; Ito, Naoki; Matsukawa, Masanori; Kato, Ryuichi; Miyamoto, Shintaro; Hinotsu, Shiro; Masumori, Naoya.
Afiliación
  • Shindo T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Maehana T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tanaka T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hashimoto K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kobayashi K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Takahashi A; Department of Urology, Hakodate Koseiin Hakodate Goryoukaku Hospital, Hakodate, Japan.
  • Hotta H; Department of Urology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
  • Kunishima Y; Department of Urology, Sunagawa City Medical Center, Sunagawa, Japan.
  • Taguchi K; Department of Urology, Oji General Hospital, Tomakomai, Japan.
  • Tachiki H; Department of Urology, Steel Memorial Muroran Hospital, Muroran, Japan.
  • Ito N; Department of Urology, NTT East Corporation Sapporo Hospital, Sapporo, Japan.
  • Matsukawa M; Department of Urology, Takikawa Municipal Hospital, Takikawa, Japan.
  • Kato R; Department of Urology, Muroran City General Hospital, Muroran, Japan.
  • Miyamoto S; Department of Urology, Japanese Red Cross Kushiro Hospital, Kushiro, Japan.
  • Hinotsu S; Department of Biostatistics, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Int J Urol ; 29(9): 1010-1016, 2022 09.
Article en En | MEDLINE | ID: mdl-35654444
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia